TG Therapeutics, Inc. ( TGTX) - Key Metrics

TGTX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $1.70 $0.05 $0.15 $0.15
2026Q1 $1.42 $0.14 -$0.12 -$0.12
2025Q4 $1.35 $0.16 $0.14 $0.14
2025Q3 $1.11 $2.69 -$0.16 -$0.16
2025Q2 $0.96 $0.19 $0.05 $0.05

TGTX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 250.18
2026Q1 0% 59.32
2025Q4 0% 46.58
2025Q3 0% 3.36
2025Q2 0% 47.36

TGTX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.27% 0%
2026Q1 -0.37% 0%
2025Q4 0.46% 0%
2025Q3 -0.44% 0%
2025Q2 0.14% 0%

TGTX

Price: $55.11

52 week price:
26.76
59.30

Payout Ratio Range:
-8.94%
0.03%

Earnings Per Share: 2.74 USD

P/E Ratio: 18.16

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 2.7 million

Ebitda: -31.6 million

Market Capitalization: 8.3 billion

Links: